Biotherapeutics & Vaccine Production

Responding to the Quest to Improve the Human Condition

New cell lines, heightened concerns about product safety, emerging biosimilars, and a vaccine industry shifting to cell culture–based production all point to a need for forward-thinking technology and product platforms. Leveraging core expertise in downstream chromatography purification, and rapid molecular-based contaminant testing, the biotherapeutics and vaccine production solutions from Applied Biosystems help solve everyday problems from improving capacity, resolution and yield to performing same-day critical impurity analyses.

• High Resolution, High Capacity Resins for Chemical Bioseparations using POROS® Chromatography Resins
• SEQ Rapid Molecular Methods for Pharmaceutical Manufacturing for Contaminant and Impurity Analysis